RZON.F Share Price Performance
US$0.16
0.00 (0.00%)
Price US$0.16
Share Pricen/a
Rize Oncology Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
RZON.F Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Rize Oncology Inc. Key Details
About RZON.F
- Founded
- 2018
- Employees
- n/a
- CEO
- WebsiteView website
Rize Oncology Inc., a biopharmaceutical company, focuses on the development of precision gene editing for human therapeutics applications. It develops STS-201, a small-molecule drug for the treatment of soft tissue sarcoma. The company was formerly known as GeneTether Therapeutics Inc. and changed its name to Rize Oncology Inc. in January 2025. Rize Oncology Inc. was incorporated in 2018 and is based in Kelowna, Canada.
